Bill
HR 3052
The Agent Orange Relief Act of 2025 enhances healthcare and financial support for Vietnam veterans and their families affected by Agent Orange exposure, addressing long-term health issues.
The Agent Orange Relief Act of 2025 aims to provide comprehensive support and relief to veterans and their families who have been adversely affected by exposure to Agent Orange during the Vietnam War. This legislation seeks to address the long-term health issues and economic hardships faced by these individuals, ensuring they receive the necessary medical care, benefits, and support services.
While the specific text of the bill is not provided, the following key provisions are anticipated based on the bill's title and legislative intent:
Expanded Health Care Benefits: The bill is expected to enhance access to healthcare services for veterans suffering from conditions linked to Agent Orange exposure, including but not limited to cancers, diabetes, and other serious health issues.
Financial Assistance: Provisions may include increased disability compensation for affected veterans and their families, as well as potential grants or funding for related health research.
Outreach and Education: The legislation may mandate outreach programs to inform veterans and their families about available benefits and resources related to Agent Orange exposure.
Support for Families: The bill could include measures to support the families of veterans who have passed away due to Agent Orange-related illnesses, possibly through survivor benefits or educational assistance.
The primary beneficiaries of the Agent Orange Relief Act of 2025 would include:
Vietnam War Veterans: Those who served in Vietnam and were exposed to Agent Orange, a herbicide used by the U.S. military during the conflict.
Veterans' Families: Spouses, children, and dependents of veterans who have suffered health consequences due to Agent Orange exposure.
Healthcare Providers: Medical professionals and facilities that provide care to affected veterans may also see changes in funding and resources.
Introduced: The bill was introduced in the House of Representatives on April 28, 2025.
Committee Referral: Following its introduction, the bill was referred to the Committee on Veterans' Affairs and the Committee on Energy and Commerce for further consideration.
Sponsor Remarks: Initial remarks by the bill's sponsors were made on April 30, 2025, indicating the bill's significance and the urgency of addressing the needs of affected veterans.
The bill is sponsored by Rashida Tlaib and has multiple cosponsors, including notable representatives such as:
The Agent Orange Relief Act of 2025 represents a critical step towards addressing the ongoing health and economic challenges faced by veterans affected by Agent Orange. By enhancing healthcare benefits, providing financial assistance, and supporting families, this legislation aims to ensure that those who served their country receive the care and recognition they deserve. As the bill progresses through the legislative process, its provisions will be closely monitored for their potential impact on veterans and their families.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
